Harnessing innate immunity in cancer therapy

Olivier Demaria,Stéphanie Cornen,Marc Daëron,Yannis Morel,Ruslan Medzhitov,Eric Vivier

DOI: https://doi.org/10.1038/s41586-019-1593-5

IF: 64.8

2019-10-02

Nature

Abstract:New therapies that promote antitumour immunity have been recently developed. Most of these immunomodulatory approaches have focused on enhancing T-cell responses, either by targeting inhibitory pathways with immune checkpoint inhibitors, or by targeting activating pathways, as with chimeric antigen receptor T cells or bispecific antibodies. Although these therapies have led to unprecedented successes, only a minority of patients with cancer benefit from these treatments, highlighting the need to identify new cells and molecules that could be exploited in the next generation of immunotherapy. Given the crucial role of innate immune responses in immunity, harnessing these responses opens up new possibilities for long-lasting, multilayered tumour control.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to use the innate immune system to enhance the effectiveness of cancer treatment. Specifically, the paper explores the role of innate immune cells in anti - tumor immune responses, including how they recognize tumors, induce and amplify adaptive immune responses, and directly exert effector functions. At the same time, it discusses the mechanisms by which these responses are suppressed in the tumor microenvironment. In addition, the paper also reviews various attempts to treat cancer by manipulating innate immune responses, especially those methods that have generated strong pre - clinical data or shown positive signals in early - stage clinical trials.

It is mentioned in the article that, although immunotherapies targeting T - cell responses (such as immune checkpoint inhibitors and chimeric antigen receptor T - cell therapies) have achieved unprecedented success, only a small number of cancer patients benefit from these treatments. Therefore, the paper emphasizes the importance of exploring new cells and molecules that can be used in next - generation immunotherapies, especially those strategies that can utilize innate immune responses. The innate immune system plays a crucial role in immunity, and using these responses can open up new possibilities for long - lasting, multi - level tumor control.